Mark Pratt

Mark Pratt is a seasoned toxicologist with extensive experience in the pharmaceutical industry. Currently serving as a Senior Toxicologist at Pierre Fabre Group since January 2024, Mark has previously held significant roles including Scientific Director and Nonclinical Safety Lead at The Janssen Pharmaceutical Companies of Johnson & Johnson from April 2018 to October 2023. Mark's expertise spans consultancy in regulatory non-clinical safety at Syneos Health, and leadership in non-clinical development at Norgine, where responsibilities included designing study programs and ensuring regulatory compliance. Mark's professional journey includes positions as a toxicologist at Pfizer, Antisoma, Covance, and Huntingdon Life Sciences. Mark holds an M.Sc in toxicology from the University of Birmingham and a degree in Biomedical Sciences from The Manchester Metropolitan University.